The development of de novo clinical practice guideline (CPG)
for proton beam therapy (PBT) in the oncological treatment of
children based on an identified health technology assessment
(HTA) in the context of very low-quality evidence and lack of
RCTs

k 2021

The development of de novo clinical practice guideline (CPG) for proton beam therapy (PBT) in the oncological treatment of children based on an identified health technology assessment (HTA) in the context of very low-quality evidence and lack of RCTs

KANTOROVÁ, Lucia, Tereza VRBOVÁ, Jitka KLUGAROVÁ a Miloslav KLUGAR

Základní údaje

Originální název

The development of de novo clinical practice guideline (CPG) for proton beam therapy (PBT) in the oncological treatment of children based on an identified health technology assessment (HTA) in the context of very low-quality evidence and lack of RCTs

Autoři

KANTOROVÁ, Lucia (703 Slovensko, domácí), Tereza VRBOVÁ (203 Česká republika, domácí), Jitka KLUGAROVÁ (203 Česká republika, domácí) a Miloslav KLUGAR (203 Česká republika, domácí)

Vydání

GIN Conference 2021, 2021

Další údaje

Jazyk

angličtina

Typ výsledku

Prezentace na konferencích

Obor

30204 Oncology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/21:00122795

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

proton beam therapy; clinical practice guideline; children

Změněno: 10. 11. 2021 09:39, Mgr. Bc. Alena Langaufová, Ph.D.

Anotace

V originále

Background The Guarantee Committee of the Czech CPG project, including the Ministry of Health of the Czech Republic, commissioned the CPG of proton beam therapy (PBT) in children due to heterogeneity of practice, the current reimbursement from public sources without underlying scientific evidence, and occasional use of PBT as the first line of treatment. Objective Is PBT more effective and safe than photon radiotherapy (PRT) in children? Methods Guideline development group (GDG) was established in 2019. We searched CPGs in 36 sources in September with no results. In October, we searched eight websites and Epistemonikos for any systematic reviews (SR) and identified exactly one relevant, high-quality HTA (Washington State Authority, 2019). We translated and updated the HTA and drafted recommendations. The expert panel will meet in September 2021. Results The evidence is of very low quality from 15 comparative observational studies and 79 case series (12 and 43 for brain tumors, 1 and 16 for head and neck tumors, 2 and 7 for eye tumors, only case series for lymphomas - 2, sarcomas - 8, bone tumors - 3. None for other tumors) that PBT can be considered for the treatment of some pediatric tumors only as an alternative to PRT. Discussion

Návaznosti

MUNI/IGA/1068/2020, interní kód MU

Název: Methodological and practical aspects of the development of guidelines and rapid guidelines in public health (Akronym: RAPguidelines-public-health)

Investor: Masarykova univerzita, Methodological and practical aspects of the development of guidelines and rapid guidelines in public health

Citovat

KANTOROVÁ, Lucia, Tereza VRBOVÁ, Jitka KLUGAROVÁ a Miloslav KLUGAR. The development of de novo clinical practice guideline (CPG) for proton beam therapy (PBT) in the oncological treatment of children based on an identified health technology assessment (HTA) in the context of very low-quality evidence and lack of RCTs. In GIN Conference 2021. 2021.

@proceedings{1802262,
   author = {Kantorová, Lucia and Vrbová, Tereza and Klugarová, Jitka and Klugar, Miloslav},
   booktitle = {GIN Conference 2021},
   keywords = {proton beam therapy; clinical practice guideline; children},
   language = {eng},
   title = {The development of de novo clinical practice guideline (CPG) for proton beam therapy (PBT) in the oncological treatment of children based on an identified health technology assessment (HTA) in the context of very low-quality evidence and lack of RCTs},
   year = {2021}
}

TY  - CONF
ID  - 1802262
AU  - Kantorová, Lucia - Vrbová, Tereza - Klugarová, Jitka - Klugar, Miloslav
PY  - 2021
TI  - The development of de novo clinical practice guideline (CPG) for proton beam therapy (PBT) in the oncological treatment of children based on an identified health technology assessment (HTA) in the context of very low-quality evidence and lack of RCTs
KW  - proton beam therapy
KW  - clinical practice guideline
KW  - children
N2  - Background The Guarantee Committee of the Czech CPG project, including the Ministry of Health of the Czech Republic, commissioned the CPG of proton beam therapy (PBT) in children due to heterogeneity of practice, the current reimbursement from public sources without underlying scientific evidence, and occasional use of PBT as the first line of treatment. Objective Is PBT more effective and safe than photon radiotherapy (PRT) in children? Methods Guideline development group (GDG) was established in 2019. We searched CPGs in 36 sources in September with no results. In October, we searched eight websites and Epistemonikos for any systematic reviews (SR) and identified exactly one relevant, high-quality HTA (Washington State Authority, 2019). We translated and updated the HTA and drafted recommendations. The expert panel will meet in September 2021. Results The evidence is of very low quality from 15 comparative observational studies and 79 case series (12 and 43 for brain tumors, 1 and 16 for head and neck tumors, 2 and 7 for eye tumors, only case series for lymphomas - 2, sarcomas - 8, bone tumors - 3. None for other tumors) that PBT can be considered for the treatment of some pediatric tumors only as an alternative to PRT. Discussion
ER  -

Podrobný výpis o publikaci